Now, I remember seeing Cinderella numerous times when I was a little kid, and to my memory, the Fairy Godmother was usually a portly old woman with flimsy looking wings rather than a large nug of dank weed. However, I know that I’d rather have some South African pot looking over my shoulder on a daily basis than a middle-aged busybody who’ll probably need a piggyback at some point down the line
The use of cannabis medications has grown in recent years for the symptomatic relief of chemotherapy-induced nausea/vomiting (CINV) and chronic pain (cancer-related and non-cancer-related). As states legalize the use of cannabis, it is important for pharmacists and other health care professionals to be aware of how to counsel patients receiving prescriptions for cannabis medications.
The hallmark of sickle cell disease (SCD) is vaso-occlusive pain that may be acute and episodic or may progress to chronic, persistent pain with unpredictable and disabling exacerbations. Patients with SCD rely on opioids almost exclusively for acute and chronic pain management. Participants reported that recently their opioid prescriptions had become more restrictive, were more closely monitored, and were increasingly difficult to fill in pharmacies. There was an emerging interest among adult patients in the consideration of the use of alternative therapies, including marijuana, to manage pain.
Geriatric patients often suffer from a long history of pain and have a limited life expectancy. Cannabinoid receptor agonists like dronabinol may be an effective, low-risk treatment option for geriatric patients with chronic pain. This study is one of the few analyses of the use of Dronabinol in geriatric patients. We show that cannabis-based drugs (in this case dronabinol) are an effective, low-risk treatment option that should be considered early in therapy. Regarding the indication spectrum, further clinical studies and an approval-free test phase are necessary.
Despite the ever-growing popularity of online multiplayer games, I still find myself drawn to single player experiences more than anything else. Any game with a solid narrative, decent controls and a world to explore is usually worthy of my time, but certain games have the potential to draw me in for a much longer duration than others. Ever since I got lost in the fantastic open worlds of Fallout and The Elder Scrolls, I’ve been waiting for a solid RPG to come along and it feels like The Outer Worlds is a worthy contender.
The Marijuana Opportunity Reinvestment and Expungement (MORE) Act passed out of committee by a vote of 24 to 10. Two Republican representatives, Matt Gaetz of Florida and Tom McClintock of California, joined the 22 democrats who voted for the bill.
Cannabinoids have been known as the primary component of cannabis for decades, but the characterization of the endocannabinoid system (ECS) in the 1990s opened the doors for cannabis’ use in modern medicine. The 2 main receptors of this system, cannabinoid receptors 1 and 2, are found on cells of various tissues, with significant expression in the gastrointestinal (GI) tract. This article hopes to create an overview of current research on cannabinoids and the ECS, detail the potential advantages and pitfalls of their use in GI diseases, and explore possible future developments in this field.
Glioma is a devastating primary tumor of the central nervous system with difficult-to-manage symptoms. Cannabis products have been postulated to potentially benefit glioma patients. Recent state legalization allowed investigators an opportunity to study glioma patients’ adoption of medical marijuana (MM). With the increasing national conversation that accompanies legalization, glioma patients are pursuing marijuana for the treatment for their symptoms. More research and education is needed to bring health care providers into the conversation.
There’s an old saying that cleanliness is next to godliness. A grow room for marijuana holds true to that saying.
By taking simple steps in maintaining a clean marijuana grow room you will reduce the risk of getting pests and disease while maintaining higher yields.
Pancreatic cancer is particularly refractory to modern therapies, with a 5-year survival rate for patients at a dismal 8%. One of the significant barriers to effective treatment is the immunosuppressive pancreatic tumor microenvironment and development of resistance to treatment. New treatment options to increase both the survival and quality of life of patients are urgently needed. This study reports on a new non-cannabinoid, non-psychoactive derivative of cannabis, termed FBL-03G, with the potential to treat pancreatic cancer.
